MEXICO CITY (Reuters) – Mexico’s foreign minister Marcelo Ebrard said on Friday that CureVac and Novavax have begun their phase III clinical trials in Mexico for a COVID-19 vaccine.
China’s CanSino Biologics Inc is due to present the results of its phase III trial, Ebrard also said.
(Reporting by Diego Ore; Writing Anthony Esposito; editing by Cassandra Garrison)
